Cell and gene therapies gain momentum in Basel
Companies specializing in the research and development of innovative cell and gene therapies continue to…
January 17, 2023 - 5 minutes
Novartis
STALICLA signs agreement with Novartis on neurodevelopmental disorders
STALICLA SA, a clinical-stage biotech company advancing the first precision neurobiology platform for patients with…
January 9, 2023 - 2 minutes
Novartis Biome UK Heart Health Catalyst 2022 winners announced
Novartis Pharmaceuticals UK has announced that Xim, creators of Lifelight, and PocDoc are the successful…
October 6, 2022 - 2 minutes
Allarity Therapeutics drug no longer commercially viable or in shareholders’ best interest
Allarity Therapeutics, after meeting with the US Food and Drug Administration (FDA), has decided a…
August 3, 2022 - 4 minutes
Radiopharmaceuticals gain traction for cancer theranostics potential
After decades of neglect from big pharma, radiopharmaceuticals are generating major oncology deals globally. This…
July 14, 2022 - 5 minutes
Novartis Pharmaceuticals UK launches health-tech investor partnership for cardiovascular care
Novartis Pharmaceuticals UK has launched the Novartis Biome UK Heart Health Catalyst 2022, in a…
July 5, 2022 - 4 minutes
A Cure for Cancer? How CAR-T Cell Therapy is Revolutionizing Oncology
CAR-T therapy has been hailed as a cure for cancer, but what really is this…
October 11, 2021 - 10 minutes
British Diagnostics Biotech Becomes Social Enterprise After Acquisition
UK rapid diagnostics company Mologic will convert into a social enterprise after being acquired by…
July 30, 2021 - 4 minutes
EMA Approvals for Multiple Sclerosis Highlight Treatment Shortfalls
While the EU saw rapid-fire approvals in the multiple sclerosis space last month, the innovations…
April 27, 2021 - 6 minutes
Update: Novartis’ Gene Therapy Zolgensma Gets Nod from EU
Update (19/05/2020): The gene therapy Zolgensma, developed by the big pharma Novartis and approved in…
May 19, 2020 - 5 minutes
Update: FDA Imposes No Penalties for Novartis Data Manipulation Scandal
Update (02/04/2020): The FDA has concluded an investigation into a data manipulation scandal surrounding the…
April 2, 2020 - 3 minutes
Novartis Enters RNA Therapeutics with Medicines Company Merger
Novartis is to acquire The Medicines Company and its late-stage RNA interference drug designed to…
November 25, 2019 - 3 minutes
